Clinical Trials in San Francisco

Showing 5561-5580 of 12,991 trials

The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)

NCT02804464

Demonstrate that the Karius Infectious Disease Diagnostic Sequencing Assay performed on plasma can accurately detect the microbiologic etiology in febrile allogeneic stem-cell transplant patients when compared with standard clinical diagnostics

Bone Marrow Transplant Infection

Karius, Inc.70 participantsStarted Jul 2016

San Francisco, California, United States

Not Yet RecruitingNA< 1 mile

Achieving Diagnostic Excellence Through Prevention and Teamwork

NCT05747755

This study seeks to link a group of hospitals to measure and share the rates of diagnostic errors, to understand underlying causes of diagnostic errors, and develop ways that hospitals, clinicians, and patients can work together to avoid diagnostic errors and harms due to those errors. The investigators will test how data sharing and collaboration improve diagnostic processes and develop approaches which can be sustained into the future. The approach represents a novel application of rigorous outcome adjudication to the problem of inpatient diagnostic errors using a learning health system model.

Diagnostic Errors

Brigham and Women's Hospital7,200 participantsStarted Mar 2023

San Francisco, California, United States • Boston, Massachusetts, United States

COMPLETEDPhase 1< 1 mile

A Safety Study of SGN-LIV1A in Breast Cancer Patients

NCT01969643

This study will examine the safety and tolerability of ladiratuzumab vedotin (LV) in patients with metastatic breast cancer. LV will be given alone or in combination with trastuzumab.

HER2 Positive Breast NeoplasmsHormone Receptor Positive Breast NeoplasmsTriple Negative Breast Neoplasms+1 more

Seagen Inc.290 participantsStarted Oct 2013

Birmingham, Alabama, United States • Scottsdale, Arizona, United States • La Jolla, California, United States +35 more locations

The DISCOVER Trial (Diagnosis of Infection in Stem Cell Transplant Patients OVER Time)

Achieving Diagnostic Excellence Through Prevention and Teamwork

A Safety Study of SGN-LIV1A in Breast Cancer Patients

Find Trials by Condition in San Francisco

Phase 1/1b Study of MGCD516 in Patients With Advanced Cancer

The PERFusion Use in Stroke Evaluation Study

Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia

Using Peer Support to Aid in Prevention and Treatment in Prediabetes

A Study to Test if TEV-48574 is Effective in Relieving Asthma

An Open Label Study of NLS-2 (Mazindol Extended Release) in Subjects With Narcolepsy

Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy

Tele-Coaching Intervention to Improve Treatment Adherence in Cystic Fibrosis

Study of Pasireotide Long Acting Release (LAR) in Patients With Metastatic Neuroendocrine Tumors (NETs)

A Study of Ubenimex in Patients With Pulmonary Arterial Hypertension (WHO Group 1)

A Study of Maribavir Compared to Valganciclovir to Treat Cytomegalovirus Infections in People Who Have Received Stem Cell Transplants

Neoadjuvant Carboplatin and Vincristine and Standard Local Ophthalmic Therapy in Treating Patients With Intraocular Retinoblastoma

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

Study to Assess the Effect of Omecamtiv Mecarbil on Exercise Capacity in Subjects With Heart Failure

Effects of Oral Levosimendan on Respiratory Function in Patients With Amyotrophic Lateral Sclerosis (ALS): Open-Label Extension

An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas

Phase 2, Open-Label, Single Arm Study, With BST-236 in Adults With R/R AML or Higher-Risk MDS